FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2468395122> ?p ?o ?g. }

• W2468395122 endingPage "1454" @default.
• W2468395122 startingPage "1448" @default.
• W2468395122 abstract "In China, the adjuvant epirubicin and docetaxel (ED) regimen is widely used as a substitute for the epirubicin and cyclophosphamide followed by docetaxel (EC-D) regimen in patients with operable breast cancer. However, their equivalence has not yet been demonstrated. This retrospective study compared these two adjuvant regimens as regards feasibility, safety and efficacy. Data on consecutive patients who received either ED (70/75 mg/m2 every 3 weeks for 6 cycles) or EC-D (70/600 mg/m2 epirubicin/cyclophosphamide followed by 75 mg/m2 docetaxel every 3 weeks for 4 cycles each) as their adjuvant chemotherapy in our center from January 2009 to January 2014, were analyzed. A total of 374 patients was enrolled, among whom 250 patients received the ED regimen, and 124 patients received the EC-D regimen. The overall median follow-up time was 38.6 months. In total, 90 and 94.4% of patients in the ED and EC-D groups, respectively, completed full cycles of chemotherapy (P=0.174). There was no difference in efficacy in terms of disease-free survival (DFS) and overall survival (OS) (DFS, P=0.919; OS, P=0.069). The incidence of neutropenia in the ED group was similar to that in the EC-D group (81.2 vs. 78.9%, P=0.660) with a similar utilization rate of granulocyte-colony stimulating factor (G-CSF; 76.9 vs. 75.2%, P=0.850). However, grade 3/4 gastrointestinal reactions were more frequently observed in the patients who received the EC-D regimen (42.0 vs. 29.2%, P=0.058). The findings of our study indicate that with similar feasibility, safety and mid-term efficacy, the adjuvant ED regimen for 6 cycles may be an alternative to the EC-D regimen in operable breast cancer." @default.
• W2468395122 created "2016-07-22" @default.
• W2468395122 creator A5013589265 @default.
• W2468395122 creator A5016935464 @default.
• W2468395122 creator A5024726679 @default.
• W2468395122 creator A5057884806 @default.
• W2468395122 creator A5060489720 @default.
• W2468395122 creator A5076517655 @default.
• W2468395122 creator A5078540705 @default.
• W2468395122 creator A5085222557 @default.
• W2468395122 creator A5089079624 @default.
• W2468395122 date "2016-06-21" @default.
• W2468395122 modified "2023-09-29" @default.
• W2468395122 title "Comparison of adjuvant ED and EC-D regimens in operable breast invasive ductal carcinoma" @default.
• W2468395122 cites W1961026612 @default.
• W2468395122 cites W1972879439 @default.
• W2468395122 cites W2069976066 @default.
• W2468395122 cites W2089265205 @default.
• W2468395122 cites W2097996372 @default.
• W2468395122 cites W2101624340 @default.
• W2468395122 cites W2107577958 @default.
• W2468395122 cites W2115228053 @default.
• W2468395122 cites W2117151785 @default.
• W2468395122 cites W2118616237 @default.
• W2468395122 cites W2120882476 @default.
• W2468395122 cites W2123528875 @default.
• W2468395122 cites W2125835228 @default.
• W2468395122 cites W2134922322 @default.
• W2468395122 cites W2142195688 @default.
• W2468395122 cites W2150706560 @default.
• W2468395122 cites W2336410037 @default.
• W2468395122 doi "https://doi.org/10.3892/ol.2016.4754" @default.
• W2468395122 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4950445" @default.
• W2468395122 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/27446451" @default.
• W2468395122 hasPublicationYear "2016" @default.
• W2468395122 type Work @default.
• W2468395122 sameAs 2468395122 @default.
• W2468395122 citedByCount "1" @default.
• W2468395122 countsByYear W24683951222019 @default.
• W2468395122 crossrefType "journal-article" @default.
• W2468395122 hasAuthorship W2468395122A5013589265 @default.
• W2468395122 hasAuthorship W2468395122A5016935464 @default.
• W2468395122 hasAuthorship W2468395122A5024726679 @default.
• W2468395122 hasAuthorship W2468395122A5057884806 @default.
• W2468395122 hasAuthorship W2468395122A5060489720 @default.
• W2468395122 hasAuthorship W2468395122A5076517655 @default.
• W2468395122 hasAuthorship W2468395122A5078540705 @default.
• W2468395122 hasAuthorship W2468395122A5085222557 @default.
• W2468395122 hasAuthorship W2468395122A5089079624 @default.
• W2468395122 hasBestOaLocation W24683951221 @default.
• W2468395122 hasConcept C121608353 @default.
• W2468395122 hasConcept C126322002 @default.
• W2468395122 hasConcept C141071460 @default.
• W2468395122 hasConcept C143998085 @default.
• W2468395122 hasConcept C2776694085 @default.
• W2468395122 hasConcept C2776755627 @default.
• W2468395122 hasConcept C2777063308 @default.
• W2468395122 hasConcept C2780835546 @default.
• W2468395122 hasConcept C2781190966 @default.
• W2468395122 hasConcept C2781413609 @default.
• W2468395122 hasConcept C530470458 @default.
• W2468395122 hasConcept C71924100 @default.
• W2468395122 hasConcept C90924648 @default.
• W2468395122 hasConceptScore W2468395122C121608353 @default.
• W2468395122 hasConceptScore W2468395122C126322002 @default.
• W2468395122 hasConceptScore W2468395122C141071460 @default.
• W2468395122 hasConceptScore W2468395122C143998085 @default.
• W2468395122 hasConceptScore W2468395122C2776694085 @default.
• W2468395122 hasConceptScore W2468395122C2776755627 @default.
• W2468395122 hasConceptScore W2468395122C2777063308 @default.
• W2468395122 hasConceptScore W2468395122C2780835546 @default.
• W2468395122 hasConceptScore W2468395122C2781190966 @default.
• W2468395122 hasConceptScore W2468395122C2781413609 @default.
• W2468395122 hasConceptScore W2468395122C530470458 @default.
• W2468395122 hasConceptScore W2468395122C71924100 @default.
• W2468395122 hasConceptScore W2468395122C90924648 @default.
• W2468395122 hasIssue "2" @default.
• W2468395122 hasLocation W24683951221 @default.
• W2468395122 hasLocation W24683951222 @default.
• W2468395122 hasLocation W24683951223 @default.
• W2468395122 hasLocation W24683951224 @default.
• W2468395122 hasOpenAccess W2468395122 @default.
• W2468395122 hasPrimaryLocation W24683951221 @default.
• W2468395122 hasRelatedWork W1548169064 @default.
• W2468395122 hasRelatedWork W1822401005 @default.
• W2468395122 hasRelatedWork W1917008458 @default.
• W2468395122 hasRelatedWork W1981040752 @default.
• W2468395122 hasRelatedWork W1986249401 @default.
• W2468395122 hasRelatedWork W2031489542 @default.
• W2468395122 hasRelatedWork W2055468688 @default.
• W2468395122 hasRelatedWork W2071771082 @default.
• W2468395122 hasRelatedWork W2079379347 @default.
• W2468395122 hasRelatedWork W2080334544 @default.
• W2468395122 hasRelatedWork W2086499497 @default.
• W2468395122 hasRelatedWork W2102032137 @default.
• W2468395122 hasRelatedWork W2118616237 @default.
• W2468395122 hasRelatedWork W2146594114 @default.
• W2468395122 hasRelatedWork W2149872810 @default.

• next